Agios Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 21.84M25.11M25.55M65.36M59.12M69.89M43.01M94.39M117.91M6.64M14.24M26.82M36.50M
Gross Profit 21.84M25.11M25.55M65.36M59.12M69.89M43.01M92.99M116.59M6.64M12.54M23.94M32.33M
Operating items
Research & Development 31.25M41.04M54.50M100.37M141.83M220.16M292.68M341.32M214.26M220.81M256.97M279.91M295.53M301.29M
Selling, General & Administrative 7.21M7.06M9.93M19.12M35.99M50.71M71.12M114.14M102.01M115.11M121.44M121.67M119.90M156.78M
Other Operating Expenses 1.40M6.64M1.70M2.88M200.00M
Operating Expenses 38.47M48.10M64.43M119.49M177.82M270.88M363.81M456.87M316.27M335.92M378.42M403.29M418.31M462.24M
Operating Income -16.63M-23.00M-38.88M-54.13M-118.70M-200.99M-320.79M-362.48M-316.27M-335.92M-378.42M-389.05M-391.49M-425.74M
EBIT -16.63M-23.00M-38.88M-54.13M-118.70M-200.99M-320.79M-362.48M-316.27M-335.92M-378.42M-389.05M-391.49M-425.74M
Non-operating items
Interest & Investment Income 0.13M0.07M0.06M0.20M0.97M2.51M6.12M16.45M14.86M6.61M0.84M12.79M33.34M48.08M
Other Non Operating Income 14.43M6.75M6.05M6.49M
Non Operating Income 14.43M6.75M6.05M6.49M
Net income details
EBT -16.50M-22.93M-38.83M-53.93M-117.73M-198.47M-314.67M-346.03M-301.41M-329.31M-356.51M-231.80M-352.09M717.97M
Tax Provisions 17.87M-9.53M-3.26M-0.43M44.24M
Profit After Tax -23.71M-20.10M-39.41M-53.50M-117.73M-198.47M-314.67M-346.03M-411.47M-329.31M1604.71M-231.80M-352.09M673.73M
Income from Continuing Operations -34.37M-13.39M-35.56M-53.50M-117.73M-198.47M-314.67M-346.03M-301.41M-329.31M-356.51M-231.80M-352.09M673.73M
Consolidated Net Income -34.37M-13.39M-35.56M-53.50M-117.73M-198.47M-314.67M-346.03M-110.06M1.94M1961.22M-231.80M-352.09M673.73M
Income towards Parent Company -34.37M-13.39M-35.56M-53.50M-117.73M-198.47M-314.67M-346.03M-110.06M1.94M1961.22M-231.80M-352.09M673.73M
Preferred Dividend Payments 3.10M7.19M4.16M
Net Income towards Common Stockholders -26.81M-27.29M-43.57M-53.50M-117.73M-198.47M-314.67M-346.03M-110.06M1.94M1961.22M-231.80M-352.09M673.73M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 31.59M34.68M37.64M42.01M57.33M58.18M68.51M69.26M54.31M54.94M55.89M57.03M
Shares Outstanding (Diluted Average) 59.99M69.00M60.45M54.79M55.65M57.89M
EBITDA -16.63M-23.00M-38.88M-54.13M-118.70M-200.99M-320.79M-362.48M-316.27M-335.92M-378.42M-389.05M-391.49M-425.74M
Shares Outstanding 33.19M33.19M31.20M37.10M37.70M42.22M48.83M58.22M68.40M69.29M70.55M
Tax Rate 0.00M0.00M0.00M0.00M